poisar

Stocks · News reference

Barclays Maintains Overweight on Marex Group, Raises Price Target to $92

Benzinga Newsdesk

Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $86 to $92.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MRX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globe Newswire

    Marex announces changes to Group Board

    Marex Group Limited announced that Chair Robert Pickering has stepped down after a three-year tenure that oversaw the company's transformation from a private firm to a NASDAQ-listed business with over $5 billion market capitalization. John Pietrowicz, former CFO of CME Group, has been appointed as the new Chair. The leadership transition comes as Marex continues its growth trajectory following its successful IPO in April 2024.

    MRXCME